Feed APYX
AP

Apyx Medical Corporation

APYX · NASDAQ

$3.02 +4.86% (+$0.14)
1M -1.31%
Market Cap $127.2M
P/E Ratio -
Div. Yield -
ROE 78.70%

Bulios Fair Price

$2.8

7.3% downside

Trenutna cena

$3.02

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica APYX trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Weak
3/9
Valuation
36 /100
Fair
P/B 11.93x
P/S 2.18x
EV/FFO N/A
Growth
38 /100
Stable
Book val. growth 27.13%
Rev. growth 5.89%
FCF growth N/A
Profitability
13 /100
Weak
Op. margin 6.06%
Gross margin 33.94%
FCF margin 18.91%
Quality
12 /100
Poor
ROA 14.14%
ROIC 7.15%
Asset turnover 0.96x
Debt
23 /100
High
Int. coverage -0.43x
Debt/Equity 3.72x
Current ratio 5.68x
Stability
51 /100
Moderate
EPS volatility 40.66%
Beta 1.31x
Profitable years 0

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o APYX
Online

O podjetju

Apyx Medical Corporation (APYX) is a company focused on the development and manufacturing of medical devices and technologies for aesthetic surgery and dermatology. Their main product is the J-Plasma® system, which combines radiofrequency energy with inert argon to create cold plasma for surgical procedures with minimal damage to surrounding tissues. This technology is utilized for various aesthetic procedures, including wrinkle removal, liposuction, skin rejuvenation, and more. Apyx Medical Corporation also focuses on developing and innovating in the field of dermatological and aesthetic medical devices to provide advanced solutions for physicians and their patients. Shares of Apyx Medical Corporation (APYX) could be suitable for investors who are tracking the healthcare sector and seeking investment opportunities in aesthetic surgery and dermatology.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Specialties

CEO

Charles D. Goodwin

Employees

205

Headquarters

Clearwater

Prihajajoči dogodki

05 NOV.

Earnings

Upcoming earnings report

51d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.